Exploration of clinical trial stakeholders perspectives towards genetic research data for future use

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2220

Full metadata record

DC Field	Value	Language
dc.contributor.author	Mr.Revana Siddappa Devarinti	-
dc.date.accessioned	2026-05-16T10:52:23Z	-
dc.date.available	2026-05-16T10:52:23Z	-
dc.date.issued	2025	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/2220	-
dc.description.abstract	ABSTRACT Introduction: Adhering to Good Clinical Practice (GCP) guidelines, it is essential that personnel engaged in clinical trials and genetic research are adequately educated and trained. Clinical trial investigators bear the responsibility to protect participant privacy and prevent the unauthorized reuse of research data. Aim: This study aims to evaluate the knowledge, attitudes, and practices (KAP) of clinical trial stakeholders regarding the reuse of genetic data for future research.	en_US
dc.language.iso	en_US	en_US
dc.publisher	KLE Academy of Higher Education and Research, Belagavi	en_US
dc.subject	Genetic Research, Bioethics, Genetic Consent Forms, Genetic Data-Coding, and Biorepository	en_US
dc.title	Exploration of clinical trial stakeholders perspectives towards genetic research data for future use	en_US
dc.type	Phd Thesis	en_US
Appears in Collections:	Faculty of Pharmacy

Files in This Item:

File	Description	Size	Format
Mr.Revana Siddappa Devarinti.pdf		21.71 MB	Adobe PDF	View/Open